Design of Clinical Drug Development Programs with Dr. Christopher D. Breder
53:28
FDA Approval Considerations with Dr. Paul Kluetz
1:01:17
Noncompartmental vs. Compartmental Approaches to Pharmacokinetic Analysis with Dr. Paolo Vicini
1:07:46
Development and Delivery of Pharmaceutical Products (CMC) - MaRS Best Practices
56:57
Dr. Emilio Emini, Ph.D. - CEO - Bill & Melinda Gates Medical Research Institute
51:04
3 PharmaceuticalStatistics Clinical Development Plan Part1
31:01
Elaine Ostrander (NIH) 1: Canine Genetics: Dog Genes Tell Surprising Tales
1:36:34
Parkinson's Disease Drugs
19:53